Expected impact of MRI-targeted biopsy interreader variability among uropathologists on ProScreen prostate cancer screening trial: a pre-trial validation study - Quiz - MDSpire

Expected impact of MRI-targeted biopsy interreader variability among uropathologists on ProScreen prostate cancer screening trial: a pre-trial validation study

  • By

  • Ronja Hietikko

  • Tuomas Mirtti

  • Tuomas P. Kilpeläinen

  • Teemu Tolonen

  • Anne Räisänen-Sokolowski

  • Stig Nordling

  • Jill Hannus

  • Marita Laurila

  • Kimmo Taari

  • Teuvo L. J. Tammela

  • Reija Autio

  • Kari Natunen

  • Anssi Auvinen

  • Antti Rannikko

  • April 6, 2024

  • 0 min

Share

Original Source(s)

Expected impact of MRI-targeted biopsy interreader variability among uropathologists on ProScreen prostate cancer screening trial: a pre-trial validation study

  • by Ronja Hietikko, Tuomas Mirtti, Tuomas P. Kilpeläinen, Teemu Tolonen, Anne Räisänen-Sokolowski, Stig Nordling, Jill Hannus, Marita Laurila, Kimmo Taari, Teuvo L. J. Tammela, Reija Autio, Kari Natunen, Anssi Auvinen, Antti Rannikko

  • April 6, 2024

Related Content

Illumination matters Part III: Impact of light obstruction on illuminance from flexible ureteroscopes — a comparative PEARLS analysis

Does non-visible haematuria require urgent assessment? A retrospective cohort study from a university teaching hospital

The combination of prostate health index and multiparametric magnetic resonance imaging in prostate cancer diagnosis: efficacy analysis in different PSA ranges and its clinical decision-guiding value